Keler Tibor

Keler Tibor is listed in filings as EXECUTIVE VP & CSO at Celldex Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2025, including 2 public disclosures. Recent filings connect the profile to Celldex Therapeutics, Inc. (CLDX). The current snapshot covers public activity from Jun 17, 2024 to Jun 9, 2025. Reported amounts are shown as $3.4M to $1.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.